Fidelis Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.58M | Buy |
32,731
+122
| +0.4% | +$20.8K | 0.51% | 37 |
|
2025
Q1 | $5.04M | Buy |
32,609
+2,636
| +9% | +$407K | 0.54% | 38 |
|
2024
Q4 | $4.55M | Buy |
29,973
+1,213
| +4% | +$184K | 0.46% | 48 |
|
2024
Q3 | $4.77M | Buy |
28,760
+2,155
| +8% | +$357K | 0.57% | 32 |
|
2024
Q2 | $4.23M | Buy |
26,605
+2,460
| +10% | +$391K | 0.6% | 34 |
|
2024
Q1 | $3.82M | Buy |
24,145
+6,938
| +40% | +$1.1M | 0.58% | 34 |
|
2023
Q4 | $2.7M | Buy |
17,207
+4,026
| +31% | +$631K | 0.6% | 35 |
|
2023
Q3 | $2.05M | Buy |
13,181
+1,992
| +18% | +$310K | 0.7% | 28 |
|
2023
Q2 | $1.85M | Buy |
11,189
+369
| +3% | +$61.1K | 0.68% | 33 |
|
2023
Q1 | $1.76M | Buy |
10,820
+6,413
| +146% | +$1.04M | 0.75% | 26 |
|
2022
Q4 | $774K | Buy |
+4,407
| New | +$774K | 0.91% | 27 |
|